Cranial manipulation affects cholinergic pathway gene expression in aged rats
Open Access
- 18 November 2021
- journal article
- research article
- Published by Walter de Gruyter GmbH in Journal of Osteopathic Medicine
- Vol. 122 (2) , 95-103
Abstract
Context: Age-dependent dementia is a devastating disorder afflicting a growing older population. Although pharmacological agents improve symptoms of dementia, age-related comorbidities combined with adverse effects often outweigh their clinical benefits. Therefore, nonpharmacological therapies are being investigated as an alternative. In a previous pilot study, aged rats demonstrated improved spatial memory after osteopathic cranial manipulative medicine (OCMM) treatment. Objectives: In this continuation of the pilot study, we examine the effect of OCMM on gene expression to elicit possible explanations for the improvement in spatial memory. Methods: OCMM was performed on six of 12 elderly rats every day for 7 days. Rats were then euthanized to obtain the brain tissue, from which RNA samples were extracted. RNA from three treated and three controls were of sufficient quality for sequencing. These samples were sequenced utilizing next-generation sequencing from Illumina NextSeq. The Cufflinks software suite was utilized to assemble transcriptomes and quantify the RNA expression level for each sample. Results: Transcriptome analysis revealed that OCMM significantly affected the expression of 36 genes in the neuronal pathway (false discovery rate [FDR] <0.004). The top five neuronal genes with the largest-fold change were part of the cholinergic neurotransmission mechanism, which is known to affect cognitive function. In addition, 39.9% of 426 significant differentially expressed (SDE) genes (FDR<0.004) have been previously implicated in neurological disorders. Overall, changes in SDE genes combined with their role in central nervous system signaling pathways suggest a connection to previously reported OCMM-induced behavioral and biochemical changes in aged rats. Conclusions: Results from this pilot study provide sufficient evidence to support a more extensive study with a larger sample size. Further investigation in this direction will provide a better understanding of the molecular mechanisms of OCMM and its potential in clinical applications. With clinical validation, OCMM could represent a much-needed low-risk adjunct treatment for age-related dementia including Alzheimer’s disease.Keywords
This publication has 54 references indexed in Scilit:
- Modified Valsalva test differentiates primary from secondary cough headacheThe Journal of Headache and Pain, 2013
- Initial studies of mechanical compression on neurogenesis with neonatal neural stem cellsNanomedicine: Nanotechnology, Biology and Medicine, 2012
- Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and CufflinksNature Protocols, 2012
- Influence of Craniosacral Therapy on Anxiety, Depression and Quality of Life in Patients with FibromyalgiaEvidence-Based Complementary and Alternative Medicine, 2011
- Lymphatic Pump Treatment Augments Lymphatic Flux of Lymphocytes in RatsLymphatic Research and Biology, 2010
- Cerebral Ventricular Changes Associated With Transitions Between Normal Cognitive Function, Mild Cognitive Impairment, and DementiaAlzheimer Disease & Associated Disorders, 2007
- The “ins” and “outs” of the high‐affinity choline transporter CHT1Journal of Neurochemistry, 2006
- Hereditary form of parkinsonism—dementiaAnnals of Neurology, 1998
- The role of the prefrontal cortex in higher cognitive functionsCognitive Brain Research, 1996
- High Affinity Choline Transporter Status in Alzheimer's Disease Tissue from Rapid AutopsyaAnnals of the New York Academy of Sciences, 1996